Two months after divorcing my wife because I believed our shattered marriage was destroying us both, I found her alone in a Chicago hospital.

Chapter 14

They began donor typing in the third week.

That was the thing I had been holding at arm’s length without admitting it: induction chemotherapy is not a cure. It is a reset. For a woman of thirty-four with high-risk AML, the actual path to living is a stem cell transplant after remission — donor stem cells that can rebuild the blood-forming system after conditioning. Without a suitable transplant strategy, her risk of relapse remained dangerously high.

I sat in Dr. Raman’s office the day the preliminary results came in.

“Tell me.”

“Her brother is not a full match,” Dr. Raman said.

Sophie had one sibling, a brother, Michael, four years older, who lived in Portland and who had come to the wedding and had been at the first Thanksgiving and who had not called his sister in a year and a half. When he heard, he flew out. He was tested. He sat in the cafeteria and let them take ten vials.

He was not a match.

“Her mother?”

“No.”

“Me?”

Dr. Raman looked at me. “Colonel, you’re not a blood relative.”

“I’m aware. Is there any situation in which a spouse—”

“No.”

I sat with it.

“So we go on the registry.”

“We have been on the registry since week one,” Dr. Raman said. “That’s the thing I need to tell you.” She turned the tablet toward me. “Sophie was flagged as high-priority urgency at the start of October. We have had a search running against eleven million donors for nine weeks.”

“And?”

“And we have three potential matches at nine out of ten. Which is not a match. Nine of ten is not ideal, and in Sophie’s case the team did not consider those candidates good enough to proceed.” She closed the tablet. “Which leaves two options. A haploidentical transplant — a half-match, usually a parent or a sibling. Or a cord blood transplant, which we can do with a mismatched unit, in some cases even a partial unit, and which buys us months.”

“Then do the haplo. Her mother—”

“Mrs. Hale is seventy percent matched, which is usable, but she’s sixty-two and has a cardiac history that makes her a poor donor.” Dr. Raman paused. “There is one more haplo candidate.”

I looked at her.

“Say it.”

“Michael. Her brother. He’s a half-match, and he’s healthy, and he’s thirty-eight.”

I closed my eyes.

“He’s not a match.”

“He’s a half-match. That’s the whole point of haplo — it’s a half.” Dr. Raman folded her hands. “It’s a real procedure. It’s been used for two decades. But it is harder on the patient than a full match. More immunosuppression, higher graft-versus-host risk, a longer and worse recovery, and Sophie’s body is already battered. It is not the safe road. It is the road that exists.”

I thought about Michael Hale, who had sat in the cafeteria for three hours and said almost nothing, and who had a tattoo on his forearm and a way of holding his coffee cup like a man who had spent his life apologizing and had gotten sick of it.

“Does he know?”

“He does. He’s been told four times. He keeps saying the same thing.” Dr. Raman looked at me. “He keeps saying it’s his sister and it doesn’t matter what it does to him.”

That was the moment I understood that this was not a problem I could solve in a green notebook. It was not a problem I could solve at all. It was a problem that fifty-eight grams and thirty-four years and eleven million strangers and one tattooed brother in Portland were going to have to solve between them.

“Then do the cord blood,” I said. “Do both. Bank the cord units, run the haplo, and do whichever comes up first.”

“Yes,” Dr. Raman said. “That is also what I would do.”